Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Mandac-Rogulj, I; Andel, J; Greil, R.
Azacitidine in acute myeloid leukemia with >30% bone marrow blasts and <15 G/L white blood cell count: Results from the Austrian Azacitidine Registry of the AGMT Study Group versus randomized controlled phase III clinical trial data.
Blood 2015. 2015; 126(23):-Annual Meeting of the American Society of Hematology; DEC 5-8, 2015; Orlando, USA.
[Poster]
Web of Science